急性非ST段抬高型心梗并发心衰的临床特点分析被引量：3

Clinical analysis of non-ST-segment elevation acute myocardial infarction complicated with acute heart failure

导出

摘要目的探讨影响NSTE-AMI患者发生心衰的危险因素。方法对69例NSTE-AMI合并心衰患者的临床特点进行回顾性分析,调查年龄、性别、体重、吸烟史、高血压病史、糖尿病史、高胆固醇血症、高尿酸血症、心电图avR ST段是否抬高及ST段下移程度等因素,首先进行单因素分析,选P<0.10的因素进行多因素非条件Logistic模型分析。结果 Logistic分析显示,急性非急性ST段抬高型心梗发生心衰与下列因素有关:年龄(OR=1.03,95%CI 1.00～1.17,P=0.03),性别(OR=1.59,95%CI 0.73～3.48,P=0.04),高血压病史(OR=2.67,95%CI 1.01～4.37,P=0.02),糖尿病史(OR=2.53,95%CI 1.05～6.13,P=0.03),高尿酸血症(OR=1.44,95%CI 1.17～1.71,P=0.00),avR ST段抬高(OR=4.35,95%CI 1.82～6.43,P=0.04),ST段下移程度(OR=3.31,95%CI 1.00～4.01,P=0.01)。结论年龄、性别、高血压病、糖尿病史、高尿酸血症、avR ST段抬高、ST段下移程度等是急性非ST抬高型心梗后发生心衰的重要危险因素。 Objective To discuss the risk factors influencing non-ST-segment elevation acute myocardial infarction occur- ing acute heart failure. Methods Reviewed 69 cases of non-ST-segment elevation acute myocardial infarction patients complicated with acute heart failure, univariate analysis was used on the factors of age, sex,weight, smoking,hypertention, diabetes,hypercholesterolemia,hyperuricemia,avR ST segment elevation,level of ST segment depression in ECG,and then non-conditional logistic model multivariate analysis was used on adjustment for the factors above. Results Acute Heart Failure occurrence in non-ST-segment elevation acute myocardial infarction cases related to age（OR = 1.03,95%CI 1.00- 1.17,P = 0.03） ,sex（OR = 1.59,95%CI 0.73-3.48,P = 0.04） ,hypertension（OR = 2.67,95%CI 1.01-4.37 ,P =0.02） ,dia- betes（OR = 2.53,95%CI 1.05-6.13,P = 0.03）,hyperuricemia（OR = 1.44,95%CI 1.17-1.71 ,P = 0.00）,avR ST elevation （OR = 4.35,95%CI 1.82-6.43,P = 0.04）,level of ST segment depression（OR = 3.31,95%CI 1.00-4.01 ,P =0.01 ）. Con- clusion The following factors of age, sex, weight, smoking, hypertention, diabetes, hyperurieemia, avR ST segment elevation, level of ST segment depression in ECG were the important risk factors influencing acute heart failure occuring in non-ST- segment elevation acute myocardial infarction cases.

作者胡松

机构地区湖南旺旺医院心内科

出处《中国现代医生》 2012年第26期13-15,共3页 China Modern Doctor

关键词急性非ST段抬高型心梗心衰危险因素 Non-ST-segment elevation acute myocardial infarction Acute heart failure Risk factor

分类号 R542.22 [医药卫生—心血管疾病] R541.6 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献10

1陈纪林,高润霖,张峻,杨跃进,姚康宝,乔树宾,秦学文,姚民.急性非Q波心肌梗死冠状动脉病变特点分析[J].中华心血管病杂志,2001,29(12):726-727. 被引量：23
2柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量：2244
3Adams KF Jr,Fonarow GC, Emerman CL,et al. Characteristics and out-comes of patients hospitalized for heart failure in the United States : ra-tionale ,design, and preliminary observations from the first 100 000 casesin the acute decompensated heart failure national registry (ADHERE )[J].Am Heart J,2005,149(2) :209-216.
4Curtis LH, Greiner MA, Hammill BG,et al. Early and long -term out-comes of heart failure in elderly persons[J]. Arch Intern Med ,2008,168?22):2481-2488.
5Kosiborod M,Lichtman JH,Heidenreich PA. et al. National trends inoutcomes among elderly patients with heart failure[J]. Am J Med, 2006,119(7):616-617.
6Ahmed A, Alima RM , Fonarow GC ,et al. Incident heart failure hospital-ization and subsequent mortality in chronic heart failure : a propensity-matched study[J]. J Card Fail,2008,14(3) ;211-218.
7Kawashiro N ,Kasanuki H, Ogawa H,et al. Clinical characteristics andoutcome of hospitalized patients with congestive heart failure results ofthe HIJCHF registry[J]. Circ J,2008,72(12) :2015-2020.
8Allan SJ, James JS, Kenneth S ,et al. Increased congestive heart failureafter myocardial infarction of modest extent in patients with diabetesmellitus[J]. Am Heart J,1984,108:31.
9Yudkin JS, Oswald GA. Hyperglycaemia, diabetes and myocardial infarc-tion[J]. Diabetes Med, 1987,4: 13.
10Barrabes JA, Figueras J, Moure C ,et al. Prognostic value of lead avRin patients with a first non-ST-segment elevation acute myocardial in-farction[J]. Circulation ,2003 ,108:814-819.

二级参考文献26

1李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量：195
2Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines(Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol,2002, 40(7) :1366-1374.
3Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J,2002,23 ( 23 ) : 1809 -1840.
4Erhardt L, Herlitz J, Bossaert L, et al. Task force on the management of chest pain. Eur Heart J, 2002, 23 ( 15 ) : 1153-1176.
5CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet, 1996, 348(9038) :1329-1339.
6Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med, 2001 , 345 ( 7 ) :494-502.
7Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet, 2001, 358(9281):527-533.
8Simoons ML, GUSTO IV-ACS Investigators. Effect of glycopmtein Ⅱb/Ⅲa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation:the GUSTO IV-ACS randomised trial. Lancet, 2001,357(9272) :1915-1924.
9Platlat Receptor Inhibitor in Ischemic Syndrome Management(PRISM) study investigator. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. Platelet Receptor Inhibition in Ischemic Syndrome Management ( PRISM )Study Investigators. N Engl J Med, 1998, 338(21 ) :1498-1505.
10Platlat Receptor Inhibitor in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms(PRISM-PLUS) study investigator. Inhibition of the platelet giycoprotein Ⅱb/Ⅲa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators. N Engl J Med,1998, 338(21) :1488-1497.